Loading clinical trials...
Loading clinical trials...
LUMINOUS: Study to Observe the Effectiveness and Safety of Ranibizumab Through Individualized Patient Treatment and Associated Outcomes
Conditions
Interventions
Ranibizumab
Ranibizumab
Locations
463
Argentina
Novartis Investigative Site
Buenos Aires, Argentina, Argentina
Novartis Investigative Site
Concepción del Uruguay, Argentina, Argentina
Novartis Investigative Site
Córdoba, Argentina, Argentina
Novartis Investigative Site
Guaymallén, Mendoza, Argentina, Argentina
Novartis Investigative Site
Rosario, Argentina, Argentina
Novartis Investigative Site
San Martin, Buenos Aires, Argentina, Argentina
Start Date
March 1, 2011
Primary Completion Date
April 1, 2016
Completion Date
April 1, 2016
Last Updated
May 23, 2016
NCT07425522
NCT07308639
NCT07449936
NCT07449923
NCT06439576
NCT07228559
Lead Sponsor
Novartis Pharmaceuticals
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions